pharmaceutical-market
Research ReportsAtopic Dermatitis Treatment Market Is Predicted to Top Us$ 7.6 Billion by 2029
Research ReportsChina Oral Solid Dosage Pharmaceutical Formulation Market Is Expected to Register a Cagr of 8.3% in the Forecasted Period 2022 to 2032
Top StoriesDrug Companies Face Covid Cliff in 2023 as Sales Set to Plummet
Top StoriesEU Must Do More to Tackle Antibiotic Shortages, Say Patient Groups
AstraZeneca Lifts 2022 Earnings Outlook as Cancer Drugs Boost Results
Date: November 10, 2022
By Natalie Grover (Reuters) -AstraZeneca raised its full-year earnings outlook on Thursday after strong sales of its key cancer drugs helped it beat quarterly profit and revenue forecasts, driving its shares to a 2-1/2 month high. The Anglo-Swedish company said it managed to grow its business in China despite protracted COVID lockdowns and was no...
New Gsk Shines Brighter With Another Forecast Upgrade
Date: November 2, 2022
By Natalie Grover (Reuters) -GSK beat third-quarter earnings forecasts on Wednesday and raised its 2022 estimate for the second time in four months, continuing its strong start as a standalone prescription medicine business since spinning off its consumer health unit. After years of underperformance relative to its peers and missing out on the lucrative market...
Energy Crisis Risks Upending Europe’s Key Medicine Supply Chains – Industry Says
Date: October 27, 2022
By Natalie Grover LONDON (Reuters) – Surging energy costs in Europe risk accelerating an exodus of companies critical in the manufacture of essential medicines, further endangering drug supply chains hit by shortages at the height of COVID-19, drug ingredient makers say. Essential medicines are crucial in treating long-term conditions as well as for surgical procedures....
Europe’s Generic Drugmakers Say They May Cut Output Due to Energy Bills
Date: September 28, 2022
By Ludwig Burger FRANKFURT (Reuters) -Europe’s drugmakers have warned they may stop making some cheap generic medicines because of surging electricity costs and are calling for an overhaul of the way they are priced, the latest industry to seek help as the energy crisis deepens. The generic drug industry lobby group Medicines for Europe, which...
Roche Diagnostics Head to Take Helm of Swiss Pharma Giant
Date: July 21, 2022
By Ludwig Burger (Reuters) -Roche’s head of diagnostics, Thomas Schinecker, is to take over as group chief executive next year, replacing Severin Schwan, who will become chairman after rejuvenating the Swiss drugmaker’s suite of treatments. Chairman Christoph Franz will not seek re-election after nine years as non-executive board chairman at the next annual shareholder meeting...
British Drugmaker Gsk Stops Supplement, Vitamin Sales to Russia
Date: April 6, 2022
(Reuters) -GlaxoSmithKline said on Wednesday its consumer arm has stopped shipments of supplements and vitamins to Russia as a result of Moscow’s invasion of Ukraine and would prioritise the supply of over-the-counter medicines for basic needs. The British drugmaker has also reiterated that it would keep supplying essential medicines and vaccines to Russia. GSK has...